Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of Levetiracetam augmentation
relative to Placebo in SSRI non-remitters with obsessive compulsive disorder. The hypothesis
is that anxiolytic effect of Levetiracetam is more beneficial when adding with a SSRI.